FDA authorized marketing of first genetic test to aid in diagnosis of Fragile X Syndrome
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) authorized marketing of the first test to…
On Feb. 21, 2020, the U.S. Food and Drug Administration (FDA) authorized marketing of the first test to…
In 2001, University of California, Davis MIND Institute team led by Randi Hagerman, Endowed Chair in Fragile X…